For the new study, researchers used a “secret-shopper” method to attempt to schedule an appointment for a patient weighing ...

MET-097i’s mid-stage performance “bodes well” for Pfizer’s buyout bid for Metsera, according to BMO Capital Markets, a deal ...

Drugs like Ozempic and Wegovy, already popular for diabetes and weight loss, may also lower the risk of some cancers, ...

Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the ...

Switching off a single enzyme in immune cells protected mice from obesity, type 2 diabetes, and fatty liver disease in a new ...

Metsera's experimental obesity drug showed significant weight loss and favorable tolerability in two mid-stage studies, the drug developer said on Monday. The injectable drug, MET-097i, led to a ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing ...

Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs ...

Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

Cannabidiol (CBD) shows promise in regulating appetite, glucose and lipid metabolism, and inflammation in preclinical models ...

A major survey by the ICMR reveals most Indians consume high-carbohydrate, low-protein diets, increasing their risk for ...

Childhood obesity in Indiana is rising, and the latest data show a challenge that is both urgent and complex. According to ...